Publication

Outpatient Treatment of Confirmed COVID-19 in Symptomatic Adults: Living, Rapid Practice Points From the American College of Physicians (Version 3)

Qaseem, Amir
Obley, Adam J
Yost, Jennifer
Abraham, George M
Andrews, Rebecca A
Jokela, Janet A
Miller, Matthew C
Humphrey, Linda L
Humphrey, Linda L
Obley, Adam J
... show 10 more
Embargo Expiration Date
Abstract

DESCRIPTION: The American College of Physicians (ACP) maintains living, rapid practice points on antiviral treatment in the outpatient setting for COVID-19.

METHODS: The Population Health and Medical Science Committee (PHMSC) developed this version 3 based on evidence from a focused update of a living, rapid review conducted by the ACP Center for Evidence Reviews at Cochrane Austria. This version addresses the SARS-CoV-2 Omicron variant and reaffirms previous practice points on the use of antiviral treatments of confirmed COVID-19 in unvaccinated or vaccinated and symptomatic patients in the outpatient setting.

RETIREMENT FROM LIVING STATUS: The PHMSC is retiring this topic from living status considering that this update and previous surveillance have not yielded important changes to the practice points.

Source

Qaseem A, Obley AJ, Yost J, Abraham GM, Andrews RA, Jokela JA, Miller MC, Humphrey LL; Population Health and Medical Science Committee of the American College of Physicians; Humphrey LL, Obley AJ, Haeme R, Krain A, Poonacha T, Saini SD, Wilt TJ, Carroll K, Etxeandia-Ikobaltzeta I, Harrod CS, Qaseem A, Shamliyan T, Vigna C, Yost J. Outpatient Treatment of Confirmed COVID-19 in Symptomatic Adults: Living, Rapid Practice Points From the American College of Physicians (Version 3). Ann Intern Med. 2026 Feb 10. doi: 10.7326/ANNALS-25-03766. Epub ahead of print. PMID: 41662713.

Year of Medical School at Time of Visit
Sponsors
Dates of Travel
DOI
10.7326/ANNALS-25-03766
PubMed ID
41662713
Other Identifiers
Notes
Funding and Acknowledgements
Corresponding Author
Related Resources
Related Resources
Repository Citation
Rights
Distribution License